Table 2.
Independent variables (n=25) associated with efficiency scores
| Observed coefficient | Standard error | p value | 95% CI | |
|---|---|---|---|---|
| Main DEA model regression results | ||||
| Typical number of visits to a health facility after diagnosis for drug-sensitive tuberculosis treatment | 0·0001 | 0·0001 | 0·4410 | −0·0001 to 0·0002 |
| Typical number of visits to a health facility after diagnosis for multidrug-resistant tuberculosis treatment | −4·53 × 10−5* | 1·86 × 10−5 | 0·0150 | −0·0001 to −8·68 × 10−6 |
| Estimated proportion of drug-sensitive tuberculosis cases who are hospitalised | −0·0816† | 0·0182 | <0·0001 | −0·1163 to −0·0441 |
| Estimated proportion of multidrug-resistant tuberculosis cases who are hospitalised | 0·0321‡ | 0·0108 | 0·0030 | 0·0105 to 0·0529 |
| Estimated average duration of stay for drug-sensitive tuberculosis cases if they are hospitalised | 0·0008† | 0·0002 | 0·0010 | 0·0003 to 0·0013 |
| Estimated average duration of stay for multidrug-resistant tuberculosis cases if they are hospitalised | 4·06 × 10−5 | 4·96 × 10−5 | 0·4120 | −0·0001 to 0·0001 |
| Governance indicators§ | −0·0217* | 0·0103 | 0·0350 | −0·0418 to −0·0011 |
| Current health expenditure per capita, PPP (current international $) | −2·09 × 10−5 | 1·70 × 10−5 | 0·2190 | −0·0001 to 1·42 × 10−5 |
| Current health expenditure (proportion of GDP) | 0·7154† | 0·1779 | <0·0001 | 0·3673 to 1·0671 |
| External health expenditure (proportion of current health expenditure) | −0·0087 | 0·0399 | 0·8270 | −0·0856 to 0·0709 |
| Out-of-pocket expenditure (proportion of current health expenditure) | −0·1677† | 0·0279 | <0·0001 | −0·2213 to −0·1124 |
| Population total (log) | 0·0035 | 0·0028 | 0·2070 | −0·0017 to 0·0089 |
| Population per km2 | −3·20 × 10−5 | 2·04 × 10−5 | 0·1170 | −0·0001 to 8·92 × 10−6 |
| Rural population (proportion of total population) | 0·0664* | 0·0259 | 0·0100 | 0·0148 to 0·1159 |
| Tuberculosis spending accounted for by external sources (proportion of total tuberculosis spending, excluding private spending) | −0·0657† | 0·0166 | <0·0001 | −0·0995 to −0·0335 |
| UHC service coverage index | 0·398† | 0·0584 | <0·0001 | 0·2816 to 0·5113 |
| Incidence of tuberculosis per 100 000 people | −0·0003† | 0·0000 | <0·0001 | −0·0004 to −0·0003 |
| Incidence of multidrug-resistant tuberculosis per 100 000 people | 0·0019‡ | 0·0007 | 0·0040 | 0·0006 to 0·0032 |
| HIV prevalence (adults age 15 to 49 years; proportion of the population) | 0·0239 | 0·1342 | 0·8590 | −0·2492 to 0·2862 |
| Population living in slums (proportion of urban population) | −0·1075† | 0·0283 | <0·0001 | −0·1618 to −0·0517 |
| Diabetes prevalence (proportion of population age ≥18 years) | 0·7799† | 0·1169 | <0·0001 | 0·5552 to 1·0119 |
| Alcohol use disorders, 12-month prevalence (proportion of population age ≥15 years) | −0·0739 | 0·1495 | 0·6210 | −0·3653 to 0·2245 |
| Gini index¶ | 0·0478 | 0·0652 | 0·4630 | −0·0810 to 0·1743 |
| Proportion of population living below the international poverty line | −0·0462 | 0·0350 | 0·1870 | −0·1138 to 0·0230 |
| Prevalence of undernourishment (proportion of population) | 0·1851† | 0·0483 | <0·0001 | 0·0898 to 0·2784 |
| Main SFA model regression results | ||||
| Typical number of visits to a health facility after diagnosis for drug-sensitive tuberculosis treatment | −1·65 × 10−5 | 2·50 × 10−5 | 0·51 | −6·54 × 10−5 to 3·24 × 10−5 |
| Typical number of visits to a health facility after diagnosis for multidrug-resistant tuberculosis treatment | 2·04 × 10−5‡ | 7·24 × 10−6 | 0·0053 | 6·22 × 10−6 to 3·46 × 10−5 |
| Estimated proportion of drug-sensitive tuberculosis cases who are hospitalised | 0·0006 | 0·0070 | 0·94 | −0·013 to 0·014 |
| Estimated proportion of multidrug-resistant tuberculosis cases who are hospitalised | 0·0061 | 0·0035 | 0·078 | −0·0007 to 0·013 |
| Estimated average duration of stay for drug-sensitive tuberculosis cases if they are hospitalised | −1·79 × 10−4‡ | 6·07 × 10−5 | 0·0032 | −2·98 × 10−4 to −6·04 × 10−5 |
| Estimated average duration of stay for multidrug-resistant tuberculosis cases if they are hospitalised | 6·79 × 10−6 | 1·24 × 10−5 | 0·58 | −1·75 × 10−5 to 3·11 × 10−5 |
| Governance indicators§ | −0·016‡ | 0·0050 | 0·0010 | −0·026 to −0·0064 |
| Current health expenditure per capita, PPP (current international $) | 2·17 × 10−5‡ | 8·16 × 10−6 | 0·0084 | 5·70 × 10−6 to 3·77 × 10−5 |
| Current health expenditure (proportion of GDP) | 0·19† | 0·060 | 0·0013 | 0·073 to 0·31 |
| External health expenditure (proportion of current health expenditure) | 0·0012 | 0·017 | 0·94 | −0·032 to 0·035 |
| Out-of-pocket expenditure (proportion of current health expenditure) | −0·037‡ | 0·012 | 0·0020 | −0·060 to −0·013 |
| Population total (log) | −0·0069† | 0·0012 | <0·0001 | −0·0093 to −0·0045 |
| Population per km2 | 3·17 × 10−5† | 8·85 × 10−6 | <0·0001 | 1·43 × 10−5 to 4·90 × 10−5 |
| Rural population (proportion of total population) | −0·030* | 0·013 | 0·023 | −0·057 to −0·0043 |
| Tuberculosis spending accounted for by external sources (proportion of total tuberculosis spending, excluding private spending) | −0·0050 | 0·0050 | 0·31 | −0·015 to 0·0047 |
| UHC service coverage index | 0·10† | 0·014 | <0·0001 | 0·075 to 0·13 |
| Incidence of tuberculosis per 100 000 people | −4·22 × 10−5† | 1·16 × 10−5 | <0·0001 | −6·49 × 10−5 to −1·95 × 10−5 |
| Incidence of multidrug-resistant tuberculosis per 100 000 people | −1·70 × 10−4 | 2·11 × 10−4 | 0·42 | −5·84 × 10−4 to 2·44 × 10−4 |
| HIV prevalence (adults age 15 to 49 years; proportion of the population) | −0·107* | 0·047 | 0·024 | −0·20 to −0·014 |
| Population living in slums (proportion of urban population) | −0·046‡ | 0·016 | 0·0042 | −0·077 to −0·014 |
| Diabetes prevalence (proportion of population age ≥18 years) | 0·046 | 0·073 | 0·53 | −0·097 to 0·19 |
| Alcohol use disorders, 12-month prevalence (proportion of population age ≥15 years) | −0·026 | 0·071 | 0·71 | −0·17 to 0·11 |
| Gini index¶ | 0·11† | 0·025 | <0·0001 | 0·056 to 0·15 |
| Proportion of population living below the international poverty line | 0·021 | 0·015 | 0·16 | −0·0079 to 0·049 |
| Prevalence of undernourishment (proportion of population) | −0·056* | 0·026 | 0·033 | −0·11 to −0·0044 |
Data are based on 1209 observations. SFA coefficients have been multiplied by −1 to show the association with efficiency, rather than inefficiency. DEA=data envelopment analysis. GDP=gross domestic product. PPP=purchasing power parity. SFA=stochastic frontier analysis. UHC=universal health coverage.
p<0·05.
p<0·001.
p<0·01.
The average of six World Governance Indicators: (1) voice and accountability, (2) political stability and absence of violence or terrorism, (3) government effectiveness, (4) regulatory quality, (5) rule of law, and (6) control of corruption.
In which a score of 0 equates to perfect equality and 100 equates to perfect inequality.